1 big thing
Dr. Sara Naseri: Menstrual blood as a diagnostic tool
Mar 7, 2024
Dr. Sara Naseri discusses using menstrual blood as a diagnostic tool, her company Qvin's FDA-cleared blood test on menstrual pads. Adriel Bettelheim on women's health innovations. Importance of inclusive women's health research funding and redefining menstrual blood as valuable for healthcare.
20:59
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Dr. Sara Naseri's Qvin reframes menstrual blood as a diagnostic tool, gaining FDA clearance for a new blood test.
- Women's health research is underfunded globally despite innovative advancements like AI-enabled ultrasound machines and monthly contraceptive pills.
Deep dives
Innovations in Women's Health
Women's health companies are innovating to address challenges from postpartum health to menopause. Discussions center around closing the gender data gap in medicine and changing perceptions of menstrual blood as an information source, rather than a taboo. Various advancements like AI-enabled ultrasound machines and monthly contraceptive pills show promise, with a focus on increasing female representation in medical studies.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
